Head and Neck Cancer — Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Citation(s)
Phase II Trial of Irinotecan Plus Cisplatin in Patients With Recurrent or Metastatic Squamous Carcinoma of the Head and Neck